Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 2015

View Archived Issues

Novel production systems of morphinan alkaloids in Saccharomyces cerevisiae

Scientists report a novel CDH1 gene mutation that causes HDGC

Celsus Therapeutics and Volution Immuno Pharmaceuticals to create orphan disease company

Genentech selects lead anti-Tau antibody from AC Immune collaboration

New assays developed for measuring rivaroxaban, dabigatran in plasma

Hemophilia candidate BAY-1093884 evaluated in animal models

GlaxoSmithKline and the Francis Crick Institute form open innovation collaboration

Cristal Therapeutics and PX Biosolutions to develop CriVac-based vaccines

Small molecule targeting c-Src SH3 domain shows promise as antithrombotic treatment

Kowa and Chugai Pharmaceutical have entered into license agreement for peretinoin

Pfizer discloses TrkA inhibitors

Novartis patents ER antagonists/degraders

Suven Life Sciences introduces 5-HT4 receptor agonists

Abbvie presents vasopressin V1b receptor ligands

Merck & Co. divulges ROMK channel blockers

Rhesus D-negative phenotype linked to complications after gastric cancer surgery

Depomed implements shareholder rights plan following Horizon Pharma takeover bid

Epirus and Polpharma establish collaboration to advance Epirus biosimilars

Takeda files NDA for ixazomib for multiple myeloma

Ferrer initiates phase IIa study of lorediplon in insomnia

CANbridge Life Sciences licenses Chinese rights to Apogenix's APG-101

Phase I/II study investigates CSJ-148 to prevent HCMV replication after stem cell transplantation

Gadovist approved for use in pediatric patients in E.U.

Cytokinetics starts phase III trial of tirasemtiv in ALS

RestorGenex reports 3-D cancer cell culture data for RES-529

Scioderm and FDA agree to rolling NDA submission for Zorblisa

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...